Bilateral transient hearing loss associated with vincristine therapy: Case report

dc.authoridSevinç, Alper/0000-0002-0499-8918
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridOZTURAN, ORHAN/0000-0002-6129-8627
dc.authorwosidSevinc, Alper/KFQ-6440-2024
dc.authorwosidSevinç, Alper/KPA-4519-2024
dc.authorwosidKAYA, Emin/W-2951-2017
dc.authorwosidOZTURAN, ORHAN/B-4984-2015
dc.contributor.authorAydogdu, I
dc.contributor.authorOzturan, O
dc.contributor.authorKuku, I
dc.contributor.authorKaya, E
dc.contributor.authorSevinc, A
dc.contributor.authorYildiz, R
dc.date.accessioned2024-08-04T20:12:11Z
dc.date.available2024-08-04T20:12:11Z
dc.date.issued2000
dc.departmentİnönü Üniversitesien_US
dc.description.abstractVincristine, adriamycin, and dexamethasone (VAD) chemotherapy protocol is first-choice treatment in newly diagnosed multiple myeloma patients in many centers. Sudden hearing loss associated with vincristine therapy is a rarely observed event in the VAD protocol. We describe a 69-year old male patient diagnosed with multiple myeloma 7 months ago who developed sudden bilateral hearing loss related to vincristine therapy. This uncommon adverse effect of vincristine is discussed and the literature reviewed.en_US
dc.identifier.doi10.1179/joc.2000.12.6.530
dc.identifier.endpage532en_US
dc.identifier.issn1120-009X
dc.identifier.issue6en_US
dc.identifier.pmid11154039en_US
dc.identifier.scopus2-s2.0-0034520588en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage530en_US
dc.identifier.urihttps://doi.org/10.1179/joc.2000.12.6.530
dc.identifier.urihttps://hdl.handle.net/11616/93270
dc.identifier.volume12en_US
dc.identifier.wosWOS:000166156600015en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherE I F T Srlen_US
dc.relation.ispartofJournal of Chemotherapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectmultiple myelomaen_US
dc.subjectvincristineen_US
dc.subjecthearing lossen_US
dc.subjecttoxicityen_US
dc.titleBilateral transient hearing loss associated with vincristine therapy: Case reporten_US
dc.typeArticleen_US

Dosyalar